A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.
暂无分享,去创建一个
Tracy T Batchelor | Richard Lugg | Andrew Menzies | Keiran Raine | Jody Clements | Sarah Edkins | Sara Widaa | Rebecca Shepherd | Andy Yates | Simon Forbes | Richard Wooster | David Jones | Helen Davies | Chris Hunter | Douglas F Easton | Michael R Stratton | David N Louis | Syd Barthorpe | Rachel Harrison | Adam Butler | Kristian Gray | Adrian Parker | Jennifer Cole | Robert Petty | M. Stratton | P. Futreal | R. Wooster | P. Stephens | S. O'meara | S. Edkins | J. Teague | A. Menzies | G. Bignell | D. Louis | G. Riggins | D. Easton | D. Cahill | C. Greenman | A. Butler | David Jones | K. Raine | H. Davies | S. Barthorpe | G. Buck | S. Forbes | R. Shepherd | Raffaella Smith | E. Dicks | A. Yates | J. Clements | T. Batchelor | S. West | S. Widaa | J. Hinton | A. Parker | C. Stevens | T. Avis | J. Cole | K. Gray | K. Halliday | R. Harrison | K. Hills | A. Jenkinson | J. Perry | David Richardson | Alexandra Small | C. Tofts | J. Varian | V. Kosmidou | R. Lugg | W. Mueller | L. Brackenbury | Matthew Gorton | Ross Laman | R. Petty | Helen Solomon | Gregory Riggins | Sarah O'Meara | Jon Teague | Ed Dicks | Claire Stevens | Calli Tofts | Tim Avis | Gemma Buck | Kelly Halliday | Katy Hills | Janet Perry | David Richardson | Alexandra Small | Jennifer Varian | Sofie West | P Andrew Futreal | Raffaella Smith | Daniel P Cahill | Philip Stephens | Chris Greenman | Graham Bignell | Lisa Brackenbury | Matthew Gorton | Jonathon Hinton | Andy Jenkinson | Vivienne Kosmidou | Ross Laman | Helen Solomon | Jennifer E Roy | Kymberly K Levine | Wolf Mueller | J. Roy | C. Hunter | Rachel E. Harrison | Rebecca Shepherd | Michael R. Stratton | Jonathon Hinton | Kymberly K. Levine | M. Stratton | Kelly Halliday | Calli Tofts | Vivian Kosmidou
[1] K. Tatsumi,et al. Spectra of spontaneous mutations at the hprt locus in colorectal carcinoma cell lines defective in mismatch repair. , 1997, Carcinogenesis.
[2] C. Richards,et al. A Homozygous Mutation in MSH6 Causes Turcot Syndrome , 2005, Clinical Cancer Research.
[3] Andrew D. Yates,et al. Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.
[4] S. Aebi,et al. The role of DNA mismatch repair in drug resistance. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] S. Levy,et al. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Meijer,et al. A Homozygous MSH6 Mutation in a Child with Café-au-Lait Spots, Oligodendroglioma and Rectal Cancer , 2004, Familial Cancer.
[7] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[8] A. Brandes,et al. Adjuvant chemotherapy in the treatment of high grade gliomas. , 2005, Cancer treatment reviews.
[9] References , 1971 .
[10] M. J. Hickman,et al. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Shapero,et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. , 2004, Genome research.
[12] Collins Vp. Amplified genes in human gliomas. , 1993 .
[13] Richard Lugg,et al. Sequence analysis of the protein kinase gene family in human testicular germ‐cell tumors of adolescents and adults , 2006, Genes, chromosomes & cancer.
[14] Á. Baross,et al. Elevated mutant frequencies and predominance of G:C to A:T transition mutations in Msh6−/− small intestinal epithelium , 2002, Oncogene.
[15] W. Thilly,et al. Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene. , 2000, Mutation research.
[16] P. Karran,et al. Human mismatch repair, drug-induced DNA damage, and secondary cancer. , 2003, Biochimie.
[17] Andrew D. Yates,et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.
[18] V. Collins. Amplified genes in human gliomas. , 1993, Seminars in cancer biology.
[19] J. Jiricny,et al. Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells , 2004, Cancer Research.
[20] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[21] T. Mak,et al. Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[23] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.